Andrew Huberman· PhD
And it turns out that if you start kids on a TNF inhibitor, they stop having strokes, all over the world. Literally, it's a life-changer.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And it turns out that if you start kids on a TNF inhibitor, they stop having strokes, all over the world. Literally, it's a life-changer.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
about 20 years ago, a doctor apparently was treating a patient with DADA2, and also treating a patient with a form of vasculitis, and treated that patient with vasculitis with what's called a TNF inhibitor. It inhibits this one cytokine called TNF. And he apparently had left TNF inhibitor in his vial, and he was like, "You know what? We've got this kid over here having all these strokes. Why don't I just try what I've got in this vial in this kid?"